Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 22, 2022 - Issue 11-12
Submit an article Journal homepage
121
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Comparison of the retention rate, safety, and efficacy of two different titration protocols for lamotrigine in newly diagnosed epilepsy patients

Ning Zhanga Department of Neurology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, 030032, Taiyuan, China;b Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, ChinaView further author information
,
Debo Yangc Department of Neurology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical SciencesTongji Shanxi Hospital, 030032, Taiyuan, ChinaView further author information
,
Cailang Niuc Department of Neurology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical SciencesTongji Shanxi Hospital, 030032, Taiyuan, ChinaView further author information
,
Penghong Lic Department of Neurology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical SciencesTongji Shanxi Hospital, 030032, Taiyuan, ChinaView further author information
,
Huiqin Wanga Department of Neurology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, 030032, Taiyuan, China;b Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, ChinaView further author information
,
Xinyi Lia Department of Neurology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, 030032, Taiyuan, China;b Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, ChinaView further author information
&
Wei Jinga Department of Neurology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, 030032, Taiyuan, China;b Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1025-1029 | Received 11 Oct 2022, Accepted 01 Dec 2022, Published online: 12 Dec 2022

References

  • Elliott JO, Moore JL, Lu B. Health status and behavioral risk factors among persons with epilepsy in Ohio based on the 2006 behavioral risk factor surveillance system. EPILEPSY BEHAV. 2008;12(3):434–444.
  • Syed TU, Sajatovic M. Extended-release lamotrigine in the treatment of patients with epilepsy. Expert Opin Pharmaco. 2010;11(9):1579–1585.
  • Perucca E, Tomson T. The pharmacological treatment of epilepsy in adults. Lancet Neurol. 2011;10(5):446–456.
  • Labate A, Fortunato F, Giugno A, et al. Perampanel as first add-on choice on the treatment of mesial temporal lobe epilepsy: an observational real-life study. NEUROL SCI. 2021;42(4):1389–1394.
  • Toledo M, Beale R, Evans JS, et al. Long-term retention rates for antiepileptic drugs: a review of long-term extension studies and comparison with brivaracetam. EPILEPSY RES. 2017;138:53–61.
  • Baulac M, Brodie MJ, Patten A, et al. Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial. LANCET NEUROL. 2012;11(7):579–588.
  • Zaccara G, Giovannelli F, Giorgi FS, et al. Tolerability of new antiepileptic drugs: a network meta-analysis. EUR J CLIN PHARMACOL. 2017;73(7):811–817.
  • Chapman SC, Horne R, Eade R, et al. Applying a perceptions and practicalities approach to understanding nonadherence to antiepileptic drugs. EPILEPSIA. 2015;56(9):1398–1407.
  • Al-Aqeel S, Gershuni O, Al-Sabhan J, et al. Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy. COCHRANE DB SYST REV. 2017;2:D8312. •• Detailed introduction of strategies for improving adherence to antiepileptic drug treatment.
  • Garnett WR. Lamotrigine: pharmacokinetics. J CHILD NEUROL. 1997;12 Suppl 1(1_suppl):S10–S15.
  • Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology. EPILEPSIA. 2017;58(4):512–521.
  • Simister RJ, Sander JW, Koepp MJ. Long-term retention rates of new antiepileptic drugs in adults with chronic epilepsy and learning disability. EPILEPSY BEHAV. 2007;10(2):336–339.
  • Mohanraj R, Brodie MJ. Measuring the efficacy of antiepileptic drugs. SEIZURE-EUR J EPILEP. 2003;12:413–443.
  • Warshavsky A, Eilam A, Gilad R. Lamotrigine as monotherapy in clinical practice: efficacy of various dosages in epilepsy. BRAIN BEHAV. 2016;6:e419. • Focus on lamotrigine as monotherapy in clinical practice.
  • Bootsma HP, Ricker L, Hekster YA, et al. The impact of side effects on long-term retention in three new antiepileptic drugs. SEIZURE-EUR J EPILEP. 2009;18(5):327–331.
  • Chung S, Wang N, Hank N. Comparative retention rates and long-term tolerability of new antiepileptic drugs. SEIZURE-EUR J EPILEP. 2007;16(4):296–304.
  • Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine monotherapy trial group. LANCET. 1995;345(8948):476–479.
  • Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. EPILEPSY RES. 1999;37(1):81–87.
  • Krumholz A, Wiebe S, Gronseth GS, et al. Evidence-based guideline: management of an unprovoked first seizure in adults: report of the Guideline Development Subcommittee of the American academy of neurology and the American epilepsy society. NEUROLOGY. 2015;84(16):1705–1713.
  • Lattanzi S, Brigo F, Cagnetti C, et al. Eslicarbazepine acetate in the treatment of adults with partial-onset epilepsy: an evidence-based review of efficacy, safety and place in therapy. Core Evid. 2018;13:21–31.
  • Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med. 2004;164(7):722–732.
  • Chandra IS, Kumar KL, Reddy MP, et al. Attitudes toward medication and reasons for non-compliance in patients with Schizophrenia. INDIAN J PSYCHOL MED. 2014;36(3):294–298.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.